Literature DB >> 3265657

Selective T cell subset depletion with anti-CD4 and anti-CD8 intact ricin immunotoxins.

M Izquierdo1, M A Balboa, A Figuera, M López-Botet.   

Abstract

In the present study we have comparatively analysed the specific activity of a panel of immunotoxins (ITs) prepared by coupling Ricin to several monoclonal antibodies (MoAbs) directed against the CD3, CD4 and CD8 T cell membrane molecules. Peripheral blood and bone marrow mononuclear cells (PBMC and BMMC) were incubated with the different ITs for 2 h, in the presence of 0.1 M lactose, washed and subsequently stimulated with either phytohemagglutinin (PHA) or an anti-CD3 MoAb. Our results indicate that the proliferative response of PBMC to both stimuli was specifically inhibited (greater than 95%) by either anti-CD3 IT or a combination of anti-CD4 and CD8 ITs, at concentrations comparable to those previously used for ex vivo T cell depletion (300 ng/ml). When used individually at the same dose, anti-CD8 and anti-CD4 ITs inhibited the PHA-induced PBMC proliferative response 40 and 70% respectively. When either anti-CD4 or anti-CD8 IT-treated cells were activated with PHA and cultured for 14 days in the presence of IL-2, less than 2% of the blasts expressed the corresponding antigens as assessed by flow cytometry analysis. Similar results were observed when BMMC were treated with the different ITs. In contrast, the growth of CFU-GM was minimally affected (0-25% inhibition). Our data indicate that ITs directed against T cell subsets are highly active and specific reagents that may be potentially useful for pre-transplant bone marrow purging.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265657      PMCID: PMC1541801     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Antigen-specific cytotoxic T cell and antigen-specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3.

Authors:  H Spits; H Yssel; J Leeuwenberg; J E De Vries
Journal:  Eur J Immunol       Date:  1985-01       Impact factor: 5.532

2.  Involvement of the CD4 molecule in a post-activation event on T cell proliferation.

Authors:  A C Carrera; F Sanchez-Madrid; M Lopez-Botet; C Bernabeu; M O De Landazuri
Journal:  Eur J Immunol       Date:  1987-02       Impact factor: 5.532

3.  The interaction of Ricinus communis agglutinin with normal and tumor cell surfaces.

Authors:  G L Nicolson; J Blaustein
Journal:  Biochim Biophys Acta       Date:  1972-05-09

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Immunotoxins: redirecting nature's poisons.

Authors:  E S Vitetta; J W Uhr
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

6.  Immunotoxins: a new approach to cancer therapy.

Authors:  E S Vitetta; K A Krolick; M Miyama-Inaba; W Cushley; J W Uhr
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

Review 7.  The preparation and cytotoxic properties of antibody-toxin conjugates.

Authors:  P E Thorpe; W C Ross
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

8.  Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease.

Authors:  A H Filipovich; D A Vallera; R J Youle; R R Quinones; D M Neville; J H Kersey
Journal:  Lancet       Date:  1984-03-03       Impact factor: 79.321

9.  Frequency and surface phenotype of human T lymphocytes producing interleukin 2. Analysis by limiting dilution and cell cloning.

Authors:  A Moretta
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

10.  Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.

Authors:  J Carlsson; H Drevin; R Axén
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

View more
  1 in total

Review 1.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.